John Bro-Jeppesen1, Jesper Kjaergaard2, Michael Wanscher3, Niklas Nielsen4, Hans Friberg5, Mette Bjerre6, Christian Hassager2. 1. Department of Cardiology, The Heart Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark. Electronic address: jbj@dadlnet.dk. 2. Department of Cardiology, The Heart Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark. 3. Department of Cardiothoracic Anaesthesia, The Heart Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark. 4. Department of Anesthesia and Intensive Care, Lund University, Helsingborg Hospital, Helsingborg, Sweden. 5. Department of Anesthesia and Intensive Care, Lund University, Skåne University Hospital, Lund, Sweden. 6. The Medical Research Laboratory, Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
Abstract
AIM: Survivors after cardiac arrest (CA) exhibits a systemic inflammatory response as part of post-cardiac arrest syndrome (PCAS). We investigated the association between systemic inflammation and severity of PCAS and whether level of targeted temperature management (TTM) modifies level of the inflammatory response. METHODS: We studied 169 patients included at a single center in the TTM-trial, randomly assigned to TTM at 33 °C or 36 °C for 24 h. Plasma samples were analyzed for inflammatory markers including interleukin (IL) IL-1β,IL-4,IL-6,IL-10, tumor necrosis factor-α (TNF-α), C-reactive protein (CRP) and procalcitonin (PCT) at randomization and 24, 48 and 72 h after CA. Severity of PCAS was assessed by Sequential Organ Failure Assessment (SOFA) score. RESULTS:Plasma levels of both IL-6 and IL-10 determined at randomization correlated with severity of PCAS at day 2 (r=0.36 and r=0.27, p<0.001) and day 3 (r=0.32 and r=0.22, p<0.001). IL-6 at randomization was an independent predictor of severity of PCAS at day 2 (p=0.003) and day 3 (p<0.0001) and was a significantly stronger predictor of severity of PCAS at day 3 compared to CRP (p=0.04) and PCT (p=0.03). Level of TTM did not modify level of the inflammatory markers IL-1β, IL-6, TNF-α, IL-4, IL-10, CRP and PCT, (p=NS for each inflammatory marker). CONCLUSIONS:Level of inflammatory response was associated with severity of PCAS with IL-6 being consistently and more strongly associated with severity of PCAS than the inflammatory markers CRP and PCT. The systemic inflammatory response after CA was not modified by TTM at 33 °C or 36 °C.
RCT Entities:
AIM: Survivors after cardiac arrest (CA) exhibits a systemic inflammatory response as part of post-cardiac arrest syndrome (PCAS). We investigated the association between systemic inflammation and severity of PCAS and whether level of targeted temperature management (TTM) modifies level of the inflammatory response. METHODS: We studied 169 patients included at a single center in the TTM-trial, randomly assigned to TTM at 33 °C or 36 °C for 24 h. Plasma samples were analyzed for inflammatory markers including interleukin (IL) IL-1β,IL-4,IL-6,IL-10, tumor necrosis factor-α (TNF-α), C-reactive protein (CRP) and procalcitonin (PCT) at randomization and 24, 48 and 72 h after CA. Severity of PCAS was assessed by Sequential Organ Failure Assessment (SOFA) score. RESULTS: Plasma levels of both IL-6 and IL-10 determined at randomization correlated with severity of PCAS at day 2 (r=0.36 and r=0.27, p<0.001) and day 3 (r=0.32 and r=0.22, p<0.001). IL-6 at randomization was an independent predictor of severity of PCAS at day 2 (p=0.003) and day 3 (p<0.0001) and was a significantly stronger predictor of severity of PCAS at day 3 compared to CRP (p=0.04) and PCT (p=0.03). Level of TTM did not modify level of the inflammatory markers IL-1β, IL-6, TNF-α, IL-4, IL-10, CRP and PCT, (p=NS for each inflammatory marker). CONCLUSIONS: Level of inflammatory response was associated with severity of PCAS with IL-6 being consistently and more strongly associated with severity of PCAS than the inflammatory markers CRP and PCT. The systemic inflammatory response after CA was not modified by TTM at 33 °C or 36 °C.
Authors: Gil B Carvalho; Ilaria Drago; Sany Hoxha; Ryuichi Yamada; Olena Mahneva; Kimberley D Bruce; Alina Soto Obando; Bruno Conti; William W Ja Journal: Proc Natl Acad Sci U S A Date: 2017-08-21 Impact factor: 11.205
Authors: J W Erath; J Hodrius; P Bushoven; S Fichtlscherer; A M Zeiher; F H Seeger; J Honold Journal: Med Klin Intensivmed Notfmed Date: 2016-11-02 Impact factor: 0.840
Authors: Matthias C Dufner; Florian Andre; Jan Stiepak; Thomas Zelniker; Emmanuel Chorianopoulos; Michael Preusch; Hugo A Katus; Florian Leuschner Journal: Cardiovasc Diagn Ther Date: 2016-06
Authors: Jerry P Nolan; Claudio Sandroni; Bernd W Böttiger; Alain Cariou; Tobias Cronberg; Hans Friberg; Cornelia Genbrugge; Kirstie Haywood; Gisela Lilja; Véronique R M Moulaert; Nikolaos Nikolaou; Theresa Mariero Olasveengen; Markus B Skrifvars; Fabio Taccone; Jasmeet Soar Journal: Intensive Care Med Date: 2021-03-25 Impact factor: 17.440
Authors: Martin Abild Stengaard Meyer; Sebastian Wiberg; Johannes Grand; Anna Sina Pettersson Meyer; Laust Emil Roelsgaard Obling; Martin Frydland; Jakob Hartvig Thomsen; Jakob Josiassen; Jacob Eifer Møller; Jesper Kjaergaard; Christian Hassager Journal: Circulation Date: 2021-03-22 Impact factor: 29.690
Authors: Kate F Kernan; Rachel P Berger; Robert S B Clark; R Scott Watson; Derek C Angus; Ashok Panigrahy; Clifton W Callaway; Michael J Bell; Patrick M Kochanek; Ericka L Fink; Dennis W Simon Journal: Resuscitation Date: 2021-07-14 Impact factor: 5.262